Prenatal Diagnostic Market by Test Type (Prenatest, Verify, Visibility, Harmony, InformaSeq, MaterniT21 PLUS, NIFTY, Panorama, Others); by End-Use (Hospitals, Clinics, Others) – United States Insights, Industry Trends, Price Trends, Growth, Size, Supply, Demand, Comparative Analysis, Competitive Market Share and Forecast, 2018-2026
Industry Trends
Prenatal diagnostics is used for testing the fetus before birth to determine certain hereditary disorders, for instance, Down's syndrome, hereditary sicknesses, chromosome abnormalities, neural tube defects, and other conditions. If high-risk is identified with the birth of a child, it can be assisted by conducting hereditary testing, common testing, and screening. The United States prenatal diagnostic market was valued at USD 527.5 Mn in 2017 and is expected to reach US$ 1,429.5 Mn by 2022.
U.S. Prenatal Diagnostic Market, By End-Use, 2017 & 2022 (USD Million)
United States prenatal diagnostics market is driven by various factors which includes, growing demand for non-invasive prenatal diagnostics, the ascent in detection rates of Down's syndrome, innovation headways, and increasing age of mothers which develops the possibility and risk of chromosomal abnormalities.
Strict administrative system and conventional ethical outlook towards prenatal testing can be a restraining factor which can critically impact the market growth. Likewise, non-invasive prenatal tests and alternative screening and testing techniques also creates obstacles for the market development.
Traditional prenatal screening and diagnostics strategies are expected to turn out of date for testing high-risk pregnant ladies which is propelling the United States prenatal diagnostics market growth. Moreover, the application of these diagnostic methods in low-risk pregnancies also boost the development of prenatal diagnostics. Presence of stringent guidelines over the diagnostic tests impart confidence in the new technology.
Prenatal Diagnostic Market, By Test Type
On the basis of test type, MaterniT21 PLUS Segment represented a major share in the U.S. Prenatal Diagnostic Market in 2016. The MaterniT21 PLUS test is indicated for use in pregnant women with increased risk for chromosomal aneuploidy. It analyzes circulating cell-free DNA extracted from a maternal blood sample. Rise in maternal age, and growing incidence of genetic abnormalities in newborns are the most significant drivers of these tests. Moreover, increased market penetration and competitive marketing methodologies by companies are further boosting the growth of these tests.
United States Prenatal Diagnostic Market
It has been reported that there are 750,000 pregnancies at high risk for fetal aneuploidy each year in the United States. The test is mainly to analyze the relative amount of 21, 18, 13, as well as X and Y chromosomal material in cell-free DNA. Increasing rate of high-risk pregnancies and rising average age for childbearing is driving the market growth particularly in developed countries such as the United States. With better advertising procedures and positioning, major companies are planning to venture in this area. Steady government research activities and increasing discretionary cash flow are some of the elements supplementing the prenatal diagnostics market in the U.S.
Competitive Landscape
The report provides both, subjective and quantitative research of the market, as well as integrates worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as M&A, affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the United States prenatal diagnostic market report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.
Market participants include Laboratory Corporation of America Holdings, Eurofins NTD, LLC, Abbott Laboratories, Hologic Inc., Illumina Inc., Natera Inc., PerkinElmer Inc., Sequenom Inc., Ariosa Diagnostics Inc., and Ravgen Inc. amongst others.
United States Prenatal Diagnostic Industry Background
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Prenatal Diagnostic Market Snapshot
3. Executive Summary: Prenatal Diagnostic Market
4. Qualitative Analysis: Prenatal Diagnostic Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. United States Prenatal Diagnostic Market Analysis and
Forecasts, 2018 – 2026
5.1. Overview
5.1.1. United States Market Revenue (US$ Mn) and Forecasts
5.2. United States Prenatal Diagnostic Market Revenue (US$ Mn) and
Forecasts, By Test Type
5.2.1. PrenaTest
5.2.1.1. Definition
5.2.1.2. Market Penetration
5.2.1.3. Market Revenue Expected to Increase by 2026
5.2.1.4. Compound Annual Growth Rate (CAGR)
5.2.2. Verifi
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.2.3. VisibiliT
5.2.3.1. Definition
5.2.3.2. Market Penetration
5.2.3.3. Market Revenue Expected to Increase by 2026
5.2.3.4. Compound Annual Growth Rate (CAGR)
5.2.4. Harmony
5.2.4.1. Definition
5.2.4.2. Market Penetration
5.2.4.3. Market Revenue Expected to Increase by 2026
5.2.4.4. Compound Annual Growth Rate (CAGR)
5.2.5. InformaSeq
5.2.5.1. Definition
5.2.5.2. Market Penetration
5.2.5.3. Market Revenue Expected to Increase by 2026
5.2.5.4. Compound Annual Growth Rate (CAGR)
5.2.6. MaterniT21 PLUS
5.2.6.1. Definition
5.2.6.2. Market Penetration
5.2.6.3. Market Revenue Expected to Increase by 2026
5.2.6.4. Compound Annual Growth Rate (CAGR)
5.2.7. NIFTY
5.2.7.1. Definition
5.2.7.2. Market Penetration
5.2.7.3. Market Revenue Expected to Increase by 2026
5.2.7.4. Compound Annual Growth Rate (CAGR)
5.2.8. Panorama
5.2.8.1. Definition
5.2.8.2. Market Penetration
5.2.8.3. Market Revenue Expected to Increase by 2026
5.2.8.4. Compound Annual Growth Rate (CAGR)
5.2.9. Others
5.2.9.1. Definition
5.2.9.2. Market Penetration
5.2.9.3. Market Revenue Expected to Increase by 2026
5.2.9.4. Compound Annual Growth Rate (CAGR)
5.3. Key Segment for Channeling Investments
5.3.1. By Test Type
6. United States Prenatal Diagnostic Market Analysis and
Forecasts, 2018 – 2026
6.1. Overview
6.2. United States Prenatal Diagnostic Market Revenue (US$ Mn) and
Forecasts, By End User
6.2.1. Hospitals
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Clinics
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.2.3. Pathology Laboratories
6.2.3.1. Definition
6.2.3.2. Market Penetration
6.2.3.3. Market Revenue Expected to Increase by 2026
6.2.3.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By End User
7. United States Prenatal Diagnostic Market Analysis and
Forecasts, 2018 – 2026
8. Competitive Benchmarking
8.1. Player Positioning Analysis
8.2. United States Presence and Growth Strategies
9. Player Profiles
9.1. Abbott Laboratories
9.1.1. Company Details
9.1.2. Company Overview
9.1.3. Product Offerings
9.1.4. Key Developments
9.1.5. Financial Analysis
9.1.6. SWOT Analysis
9.1.7. Business Strategies
9.2. Agilent Technologies
9.2.1. Company Details
9.2.2. Company Overview
9.2.3. Product Offerings
9.2.4. Key Developments
9.2.5. Financial Analysis
9.2.6. SWOT Analysis
9.2.7. Business Strategies
9.3. Ariosa Diagnostics, Inc.
9.3.1. Company Details
9.3.2. Company Overview
9.3.3. Product Offerings
9.3.4. Key Developments
9.3.5. Financial Analysis
9.3.6. SWOT Analysis
9.3.7. Business Strategies
9.4. BGI Diagnostics
9.4.1. Company Details
9.4.2. Company Overview
9.4.3. Product Offerings
9.4.4. Key Developments
9.4.5. Financial Analysis
9.4.6. SWOT Analysis
9.4.7. Business Strategies
9.5. CombiMatrix
9.5.1. Company Details
9.5.2. Company Overview
9.5.3. Product Offerings
9.5.4. Key Developments
9.5.5. Financial Analysis
9.5.6. SWOT Analysis
9.5.7. Business Strategies
9.6. Counsyl, Inc.
9.6.1. Company Details
9.6.2. Company Overview
9.6.3. Product Offerings
9.6.4. Key Developments
9.6.5. Financial Analysis
9.6.6. SWOT Analysis
9.6.7. Business Strategies
9.7. Eurofins NTD, LLC.
9.7.1. Company Details
9.7.2. Company Overview
9.7.3. Product Offerings
9.7.4. Key Developments
9.7.5. Financial Analysis
9.7.6. SWOT Analysis
9.7.7. Business Strategies
9.8. Hologic Inc.
9.8.1. Company Details
9.8.2. Company Overview
9.8.3. Product Offerings
9.8.4. Key Developments
9.8.5. Financial Analysis
9.8.6. SWOT Analysis
9.8.7. Business Strategies
9.9. Illumina, Inc.
9.9.1. Company Details
9.9.2. Company Overview
9.9.3. Product Offerings
9.9.4. Key Developments
9.9.5. Financial Analysis
9.9.6. SWOT Analysis
9.9.7. Business Strategies
9.10. Laboratory Corporation of America Holdings
9.10.1. Company Details
9.10.2. Company Overview
9.10.3. Product Offerings
9.10.4. Key Developments
9.10.5. Financial Analysis
9.10.6. SWOT Analysis
9.10.7. Business Strategies
9.11. LifeCodexx AG
9.11.1. Company Details
9.11.2. Company Overview
9.11.3. Product Offerings
9.11.4. Key Developments
9.11.5. Financial Analysis
9.11.6. SWOT Analysis
9.11.7. Business Strategies
9.12. Natera, Inc.
9.12.1. Company Details
9.12.2. Company Overview
9.12.3. Product Offerings
9.12.4. Key Developments
9.12.5. Financial Analysis
9.12.6. SWOT Analysis
9.12.7. Business Strategies
9.13. PerkinElmer, Inc.
9.13.1. Company Details
9.13.2. Company Overview
9.13.3. Product Offerings
9.13.4. Key Developments
9.13.5. Financial Analysis
9.13.6. SWOT Analysis
9.13.7. Business Strategies
9.14. PREMAITHA HEALTH
9.14.1. Company Details
9.14.2. Company Overview
9.14.3. Product Offerings
9.14.4. Key Developments
9.14.5. Financial Analysis
9.14.6. SWOT Analysis
9.14.7. Business Strategies
9.15. Progenity, Inc.
9.15.1. Company Details
9.15.2. Company Overview
9.15.3. Product Offerings
9.15.4. Key Developments
9.15.5. Financial Analysis
9.15.6. SWOT Analysis
9.15.7. Business Strategies
9.16. Quest Diagnostics Incorporated
9.16.1. Company Details
9.16.2. Company Overview
9.16.3. Product Offerings
9.16.4. Key Developments
9.16.5. Financial Analysis
9.16.6. SWOT Analysis
9.16.7. Business Strategies
9.17. Ravgen, Inc.
9.17.1. Company Details
9.17.2. Company Overview
9.17.3. Product Offerings
9.17.4. Key Developments
9.17.5. Financial Analysis
9.17.6. SWOT Analysis
9.17.7. Business Strategies
9.18. Sequenom, Inc.
9.18.1. Company Details
9.18.2. Company Overview
9.18.3. Product Offerings
9.18.4. Key Developments
9.18.5. Financial Analysis
9.18.6. SWOT Analysis
9.18.7. Business Strategies
Note: This ToC is
tentative and can be changed according to the research study conducted during
the course of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
